70
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Self-reported experiences as predictors for onset of psychotropic medication. A prospective study of healthy draftees

, , &
Pages 298-304 | Accepted 26 Oct 2012, Published online: 06 Dec 2012

References

  • Häfner H, Löffler W, Maurer K, Hambrecht M, an der Heiden, W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 1999;100:105–18.
  • Yung AR, McGorry PD. The prodromal phase of first episode psychosis: Past and current conceptualizations. Schizophr Bull 1996;22:353–70.
  • Miller TI, McGlashan TH, Woods SW, Stein K, Driesen N, Concran CM, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Quater 1999;70:273–87.
  • Yung AR, Phillips LJ, McGorry, PD, McFarlane CA, Francey S, Harrigan S, et al. Prediction of psychosis: A step towards indicated prevention of schizophrenia. Br J Psyschiatry 1998;172 Suppl 33:14–20.
  • Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001;58:158–64.
  • Davidson M, Reichenberg A, Rabinpwitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 1999;156:1328–35.
  • Lewis G, David AS, Malmberg A, Allebeck P. Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study. Br J Psychiatry 2000;177:416–20.
  • Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Bodner E, et al. Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia. Arch Gen Psychiatry 2001;58:959–64.
  • Reihenberg A, Goldenberg J. Self-reported mental health difficulties and subsequent risk for schizophrenia in females: A 5-year follow-up cohort study. Schizophr Res 2006;82:233–9.
  • Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J. The incidence and outcome of subclinical psychotic experiences in the general population. Br J Clin Psychol 2005;44(Pt 2):181–91.
  • Fullerton CA, Busch AB, Normand SL, McGuire TG, Epstein AM. Ten-year trends in quality of care and spending for depression: 1996 through 2005. Arch Gen Psychiatry 2011;68:1218–26.
  • Heinimaa M, Salokangas RK, Ristkari T, Plathin M, Huttunen J, Ilonen T, et al. PROD-screen—A screen for prodromal symptoms of psychosis. Int J Meth Psychiatr Res 2003;12:92–104.
  • Almqvist F, Ikäheimo K, Kumpulainen K, Tuompo-Johansson E, Linna SL, Puura K, et al. Design and subjects of a Finnish epidemiological study on psychiatric disorders in childhood. Eur Child Adolesc Psychiatry 1999;8 Suppl IV:3–6.
  • Haavisto A, Sourander A, Multimäki P, Parkkola K, Santalahti P, Helenius H, et al. Factors associated with depressive symptoms among 18-year-old boys: A prospective 10-year follow-up study. J Affect Disord 2004;83:143–54.
  • Conrad K. Die beginnende Schizophrenie. Thieme Verlag, Stuttgart; 1958.
  • Gyllenberg D, Sourander A, Niemelä S, Helenius H, Sillanmäki L, Ristkari T, et al. Childhood predictors of use and costs of antidepressant medication by age 24 years: Findings from the Finnish Nationwide 1981 Birth Cohort Study. J Am Acad Child Adolesc Psychiatry. 2011;50:406–15.
  • Sourander A, Ellilä H, Välimäki M, Aronen ET. Psychopharmacological treatment of child and adolescent psychiatric inpatients in Finland. J Child Adolesc Psychopharmacol 2002;12:147–55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.